Wells Fargo & Company Increases Kymera Therapeutics (NASDAQ:KYMR) Price Target to $42.00
Kymera Therapeutics (NASDAQ:KYMR - Get Rating) had its price objective increased by Wells Fargo & Company ...
Read moreKymera Therapeutics (NASDAQ:KYMR - Get Rating) had its price objective increased by Wells Fargo & Company ...
Read more© 2022 TheDailyStock.News